Chronic insomnia is highly prevalent and affects approximately 30% of the general population. Insomnia impairs daytime function and results in decreased quality of life. Despite its burden, insomnia continues to be inadequately identified, evaluated and treated in clinical practices. Several diagnostic criteria and classification systems exist for the evaluation of insomnia but there continue to lack a standardized definition of insomnia and guidelines for assessment. In recognition of this problem, research diagnostic criteria and practice parameters for insomnia has been formulated by the American Academy of Sleep Medicine.
Introduction
Insomnia is the most common sleep disorder in the general adult population, and has become a major health-care concern over recent years. Approximately one third (33% to 50%) of the population reports one or more insomnia symptoms, and 10 to 15% suffers from chronic insomnia with daytime consequences. 1 When chronic, insomnia is associated with daytime impairment, including decreased quality of life, increased risk for psychiatric disturbances, and impaired occupational performance. Despite these individual and societal risks, insomnia continues to be inadequately identified and treated by clinicians.
The purpose of this paper is to review (1) the recent insomnia definitions and classifications; (2) the assessment strategies used in the clinical evaluation of insomnia.
Definition of insomnia
The three most widely used diagnostic manuals for sleep however, frequency of symptoms is noted only in ICD-10. 
Prevalence of insomnia
As a result of the heterogeneity among insomnia definitions, prevalence of insomnia vary widely, from 10% to 40%, depending upon the definition used. 1 Studies of the prevalence estimated approximately 30% of the general population having one or more symptoms of insomnia, and 5% to 10% having a specific insomnia disorder.
Prevalence rates for chronic insomnia are generally higher in women and older adults. In women, insomnia is more prevalent with both the onset of menses and menopa- 
Pathophysiology of insomnia
Insomnia is believed to be a disorder of hyperarousal experienced throughout the day and night. This arousal is currently explained by both cognitive and physiological models of insomnia.
The cognitive model suggests that worry and rumina- Physiological arousal has been demonstrated through measurements of the whole body metabolic rate, heart rate variability, neuroendocrine measures, and functional neuroimaging 3, 4 : (1) insomnia patients have been found to exhibit higher metabolic rates than the healthy controls; (2) average heart rates were increased and variability was decreased in all stages of sleep in insomnia patients compared to healthy normal sleepers; (3) urinary and plasma levels of cortisol and adrenocorticotropic hormone (ACTH) were higher in poor sleepers; and (4) insomniacs showed greater cerebral glucose metabolism during sleep compared to healthy subjects.
Model of the evolution of insomnia
The evaluation of chronic insomnia is enhanced by a working model, developed by Spielman and colleagues, that takes into account the evolution of the insomnia disorder ( Fig. 1 ). 5 The model suggests that there are factors that initially predispose an individual to develop insomnia, factors that precipitate the insomnia episode, and factors that maintain the insomnia once it has developed.
Predisposing factors are inherent characteristics of the individual that increase susceptibility to insomnia. Predisposing factors alone do not cause insomnia but may decrease the threshold for its onset. 
Sleep History
The sleep history should include the following compo- 
